arrow
返回
V

Véronique Dièras

centre eugene marquis

85H指数
624论文数
4.3W被引数
收录论文 119
发表时间
Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database人表皮生长因子受体2低表达、激素受体阳性转移性乳腺癌的化疗结局:来自法国多中心ESME数据库的见解
errBreast
IF7.9
err2026-09-27
err0
errOAAI
errWilliam Jacot; Pauline Macouillard; Suyuan Zhang; Danalyn Byng; Shannon Hunter; Vincent Massard; Jean-Sébastien Frenel; David Pérol; Etienne Brain; Audrey Mailliez; Thomas Bachelot; Monica Arnedos; Lise Bosquet; Véronique Diéras
err分享
err收藏
Summary of Research: HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast CancerHER2CLIMB-05研究总结:曲拉妥尼(Tucatinib)对比安慰剂联合曲妥珠单抗和帕妥珠单抗用于HER2阳性转移性乳腺癌的一线维持治疗的三期研究
err2026-09-19
err0
errOAAI
errVeronique Dieras; Giuseppe Curigliano; Miguel Martin; Florence Lerebours; Junji Tsurutani; Marie-France Savard; Katarzyna J. Jerzak; Xichun Hu; Ciara C. O’Sullivan; Eriko Tokunaga; Alicia Okines; Chiun-Sheng Huang; William Jacot; Joohyuk Sohn; Eduardo Cronemberger Silva; Volkmar Mueller; Shan Yang; Giovanna Granata; Qi Shen; Erika Hamilton
err分享
err收藏
Comparative performance of a targeted next-generation sequencing assay against multiplexed digital PCR assays in detecting ERBB2, ESR1, and PIK3CA mutations in plasma circulating cell-free DNA from liquid biopsies靶向下一代测序检测液体活检血浆游离DNA中ERBB2、ESR1和PIK3CA突变的性能与多重数字PCR检测方法的比较
err2025-10-08
err0
PREAI
errJulien Corné; Florence Godey; Angelina Legros; Laurent Castéra; Sophie Krieger; Mathilde Cherel; Agathe Cochet; Fanny Le Du; Héloïse Bourien; Antoine Deleuze; Laurence Crouzet; Christophe Perrin; Claudia Lefeuvre-Plesse; Véronique Diéras; Thibault De la Motte Rouge
err分享
err收藏
Real-world treatment patterns and effectiveness after disease progression on CDK4/6 inhibitors for HR-positive/HER2-negative metastatic breast cancer in the ESME-MBC cohortCDK4/6抑制剂治疗后疾病进展的HR阳性/HER2阴性转移性乳腺癌患者中真实世界的治疗模式与疗效:ESME-MBC队列研究
err2025-09-17
err0
PREAI
errR. Varnier; D. Pérol; W. Jacot; A. Mailliez; V. Diéras; F. Dalenc; A. Gonçalves; C. Levy; M. Arnedos; J.-S. Frenel; C. Bailleux; V. Massard; E. Brain; B. Sauterey; A.-M. Savoye; L. Bosquet; J.-C. Thery; T. Petit; T. Bachelot; T. Grinda; I. Ray-Coquard
err分享
err收藏
Brain imaging screening in metastatic breast cancer: patients’ and physicians’ perspectives脑成像筛查在转移性乳腺癌中的应用:患者和医师的视角
err2025-08-12
err0
errOAAI
errLeonor Matos; Mette van Ramshorst; Volkmar Müller; Elisa Agostinetto; Sabine Linn; Matteo Lambertini; Veronique Dieras; Fanny le Du; Sofia Braga; Carmen Criscitiello; Katarzyna J. Jerzak; Gil Morgan; Sara Brucker; Patricia von Kroge; Renate Haidinger; Gema Rodríguez Recio; Eva Schumacher-Wulf; Mario Fontes Sousa; Francesco Schettini; Elena Laakmann
err分享
err收藏
The association of high body mass index with the safety and efficacy of sacituzumab govitecan in patients with metastatic triple-negative breast cancer from the ASCENT studyASCENT研究中,体重指数与转移性三阴性乳腺癌患者中sacituzumab govitecan的安全性和有效性之间的关联
err2025-06-01
err0
errOAAI
errL. García-Estévez; A. Bardia; H.S. Rugo; L.A. Carey; V.C. Diéras; S. Loibl; M. Piccart; L. Gianni; K. Kalinsky; J. O’Shaughnessy; S.A. Hurvitz; E. Harting; T. Valdez; S. Phan; C. Lai; J. Cortés
err分享
err收藏
Summary of quality of life in the ASCENT phase 3 clinical trial for people with metastatic triple-negative breast cancer : A plain language summary
err2024-09-26
err0
errOAAI
errLoibl, Sibylle; Loirat, Delphine; Tolaney, Sara M.; Punie, Kevin; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Shah, Anuj; Phan, See; Shi, Ling; Spears, Patricia A.; Piccart, Martine J.
err分享
err收藏
Unraveling the mechanisms of action and resistance to trastuzumab deruxtecan (T-DXd): Supplementary biomarker analyses from DAISY trial揭示曲妥珠单抗德鲁替康(T-DXd)的作用机制和耐药机制:DAISY试验的补充生物标志物分析
err2024-09-01
err0
PREAI
errMosele, M. F.; Lusque, A.; Dieras, V. C.; Deluche, E.; Ducoulombier, A.; Pistilli, B.; Bachelot, T.; Viret, F.; Levy, C.; Pradat, Y. C.; Signolle, N.; Le Bescond, L.; Tran, D.; Droin, N.; Kobayashi, M.; Kakewaga, T.; Deloger, M.; Jimenez, M.; Lacroix-Triki, M.; Andre, F.
err分享
err收藏
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer (vol 10, 33, 2024)
err2024-07-09
err1
errOAAI
errHurvitz, Sara A.; Bardia, Aditya; Punie, Kevin; Kalinsky, Kevin; Carey, Lisa A.; Rugo, Hope S.; Dieras, Veronique; Phan, See; Delaney, Rosemary; Zhu, Yanni; Tolaney, Sara M.
err分享
err收藏
Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer (vol 8, 98, 2022)sacituzumab govitecan治疗转移性三阴性乳腺癌的3期ASCENT试验的安全性分析 (第8、98、2022卷)
err2024-06-06
err0
errOAAI
errRugo, Hope S.; Tolaney, Sara M.; Loirat, Delphine; Punie, Kevin; Bardia, Aditya; Hurvitz, Sara A.; O'Shaughnessy, Joyce; Cortes, Javier; Dieras, Veronique; Carey, Lisa A.; Gianni, Luca; Piccart, Martine J.; Loibl, Sibylle; Goldenberg, David M.; Hong, Quan; Olivo, Martin; Itri, Loretta M.; Kalinsky, Kevin
err分享
err收藏
Phase 3 Study of Tucatinib or Placebo in Combination With Trastuzumab and Pertuzumab as Maintenance Therapy for HER2+Metastatic Breast Cancer (HER2CLIMB-05, Trial in Progress)
err2024-05-02
err0
PREAI
errHamilton, Erika; Tsurutani, Junji; Curigliano, Giuseppe; Martin, Miguel; O'Sullivan, Ciara; Sohn, Joo Hyuk; Tryfonidis, Konstantinos; Santarpia, Libero; Yang, Shan; Dieras, Veronique
err分享
err收藏
Subgroup analyses from the phase 3 ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer
err2024-04-25
err16
errOAAI
errHurvitz, Sara A.; Bardia, Aditya; Punie, Kevin; Kalinsky, Kevin; Carey, Lisa A.; Rugo, Hope S.; Dieras, Veronique; Phan, See; Delaney, Rosemary; Zhu, Yanni; Tolaney, Sara M.
err分享
err收藏
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): Final overall survival results from a randomized phase 3 trialVeliparib联合卡铂和紫杉醇治疗BRCA突变的晚期乳腺癌 (BROCADE3): 一项随机3期试验的最终总生存期结果
err2024-03-01
err4
PREAI
errDieras, Veronique; Hanc, Hyo S.; Wildiers, Hans; Friedlander, Michael; Ayoub, Jean- Pierre; Puhalla, Shannon L.; Loirat, Delphine; Ratajczak, Christine; Adamu, Hephzibah; Girardi, Vincent; Arun, Banu K.
err分享
err收藏
Plasma-based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer通过多重数字PCR对大量转移性乳腺癌患者的ERBB2突变状态进行基于血浆的分析
err2024-01-29
err4
errOAAI
errCorne, Julien; Quillien, Veronique; Godey, Florence; Cherel, Mathilde; Cochet, Agathe; Le Du, Fanny; Robert, Lucie; Bourien, Heloise; Brunot, Angelique; Crouzet, Laurence; Perrin, Christophe; Lefeuvre-Plesse, Claudia; Dieras, Veronique; de la Motte Rouge, Thibault
err分享
err收藏
The effects of adding palbociclib to endocrine therapy to treat advanced breast cancer: a plain language summary of a study using the PALOMA-2 and PALOMA-3 trial results
err2023-11-02
err1
errOAAI
errRugo, Hope S.; Im, Seock-Ah; Joy, Anil A.; Shparyk, Yaroslav; Walshe, Janice M.; Sleckman, Bethany; Loi, Sherene; Theall, Kathy Puyana; Kim, Sindy; Huang, Xin; Bananis, Eustratios; Mahtani, Reshma; Finn, Richard S.; Dieras, Veronique
err分享
err收藏
Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial
err2023-07-24
err130
errOAAI
errMosele, Fernanda; Deluche, Elise; Lusque, Amelie; Le Bescond, Loic; Filleron, Thomas; Pradat, Yoann; Ducoulombier, Agnes; Pistilli, Barbara; Bachelot, Thomas; Viret, Frederic; Levy, Christelle; Signolle, Nicolas; Alfaro, Alexia; Tran, Diep T. N.; Garberis, Ingrid Judith; Talbot, Hugues; Christodoulidis, Stergios; Vakalopoulou, Maria; Droin, Nathalie; Stourm, Aurelie; Kobayashi, Maki; Kakegawa, Tomoya; Lacroix, Ludovic; Saulnier, Patrick; Job, Bastien; Deloger, Marc; Jimenez, Marta; Mahier, Celine; Baris, Vianney; Laplante, Pierre; Kannouche, Patricia; Marty, Virginie; Lacroix-Triki, Magali; Dieras, Veronique; Andre, Fabrice
err分享
err收藏
Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients
err2023-05-01
err4
errOAAI
errCorne, Julien; Quillien, Veronique; Callens, Celine; Portois, Pascal; Bidard, Francois-Clement; Jeannot, Emmanuelle; Godey, Florence; Le Du, Fanny; Robert, Lucie; Bourien, Heloise; Brunot, Angelique; Crouzet, Laurence; Perrin, Christophe; Lefeuvre-Plesse, Claudia; Dieras, Veronique; Rouge, Thibault De la Motte
err分享
err收藏
Phase 3 study of tucatinib or placebo in combination with trastuzumab and pertuzumab as maintenance therapy for HER2+metastatic breast cancer (HER2CLIMB-05, trial in progress)
err2023-04-14
err0
PREAI
errHamilton, Erika; Tsurutani, Junji; Sohn, Joohyuk; Curigliano, Giuseppe; O'Sullivan, Ciara C.; Martin, Miguel; Tryfonidis, Konstantinos; Santarpia, Libero; Yang, Shan; Dieras, Veronique
err分享
err收藏
ER+, HER2-advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes
err2023-03-25
err0
errOAAI
errChen, Jessica W.; Jacot, William; Cortes, Javier; Krop, Ian E.; Dent, Susan; Harbeck, Nadia; De Laurentiis, Michelino; Dieras, Veronique; Im, Young-Hyuck; Stout, Thomas J.; Schimmoller, Frauke; Savage, Heidi M.; Hutchinson, Katherine E.; Wilson, Timothy R.
err分享
err收藏